T4前列腺癌局部治疗与系统治疗的比较效果
该回顾性队列研究基于美国国家癌症数据库2004至2013年1914例临床T4N0-1M0前列腺癌患者,比较局部治疗与系统治疗的总生存。多因素分析显示局部治疗与总生存提高相关(HR=0.52,95%CI 0.44-0.62,P<.001),但研究为非随机设计,需临床试验进一步验证。
要点
- 临床T4N0-1M0前列腺癌中,局部治疗较系统治疗与总生存提高相关(HR=0.52)。
- 局部治疗中放疗和手术均较系统治疗与总生存提高相关。
- 因回顾性非随机设计,局部治疗疗效需临床试验进一步明确。
核心结论
- 临床T4前列腺癌局部治疗与总生存提高相关,但需临床试验验证。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库2004至2013年临床T4N0-1M0前列腺癌患者1914例。
主要发现
- 局部治疗组1559例,系统治疗组355例,5年中位生存分别为41.5个月和28.2个月。
- 多因素分析局部治疗较系统治疗总生存提高(HR=0.52;95%CI 0.44-0.62,P<.001)。
- 放疗(HR=0.44;95%CI 0.36-0.53,P<.001)和手术(HR=0.67;95%CI 0.55-0.82,P<.001)均较系统治疗与总生存提高相关。
- 局部治疗中放疗709/1559例(45.5%)、手术560/1559例(35.9%)、联合放疗加手术290/1559例(18.6%),5年总生存分别为61%、51.4%和62.2%。
临床怎么用
- 对于临床T4N0-1M0前列腺癌患者,局部治疗可能较单纯系统治疗改善总生存。
局限性
- 研究为回顾性、非随机设计,需临床试验更好定义局部治疗疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the comparative effectiveness of local vs systemic therapy among patients diagnosed with nonmetastatic clinical T4 prostate cancer. METHODS: Using the National Cancer Database men with clinical T4N0-1M0 prostate cancer from 2004 to 2013 were identified. Local therapy was defined as radiation (RT with androgen deprivation therapy [ADT]), surgery (radical prostatectomy with ADT), or combined radiation plus surgery (radical prostatectomy plus RT with ADT). Systemic therapy was defined as ADT or chemotherapy alone. The primary outcome of overall survival was estimated using the Kaplan-Meier method. Factors associated with overall survival were determined by Cox proportional hazards models. RESULTS: A total of 1914 patients were included in our analysis, 1559 received local therapy and 355 received systemic therapy. Median 5-year survival for local vs systemic therapy was 41.5 and 28.2 months, respectively. On multivariable analysis, local therapy was associated with increased overall survival compared to systemic therapy (hazard ratio [HR] = 0.52; 95% confidence interval [CI] 0.44-0.62, P < .001). Comparing local therapy treatment modalities, both radiation (HR = 0.44; 95% CI 0.36-0.53, P < .001) and surgery (HR = 0.67; 95% CI 0.55-0.82, P < .001) were associated with increased overall survival compared to systemic therapy. Among those receiving local therapy, more patients were treated with radiation (n = 709/1559 or 45.5%) compared to surgery (n = 560/1559 or 35.9%) or combined radiation plus surgery (n = 290/1559 or 18.6%) with 5-year overall survival by treatment type being 61%, 51.4%, and 62.2%, respectively. CONCLUSION: Local therapy for clinical T4 prostate cancer is associated with improved overall survival. Due to the retrospective, nonrandomized nature of the study design, a clinical trial is needed to better define the efficacy of local therapy in this high-risk patient population.
引用
- Kim AH, Konety B, Chen Z, et al. Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. Urology. 2018. PMID: 29990574. doi:10.1016/j.urology.2018.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。